Results 1 to 10 of about 2,811 (122)

Identification of putative steroid receptor antagonists in bottled water: combining bioassays and high-resolution mass spectrometry. [PDF]

open access: yesPLoS ONE, 2013
Endocrine disrupting chemicals (EDCs) are man-made compounds interfering with hormone signaling and thereby adversely affecting human health. Recent reports provide evidence for the presence of EDCs in commercially available bottled water, including ...
Martin Wagner   +3 more
doaj   +8 more sources

Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple Sclerosis [PDF]

open access: yesNeurology and Therapy
Introduction Multiple sclerosis (MS) is a heterogeneous disease that disproportionately impacts Black people with MS (PwMS), who experience more severe disease and higher relapse rates compared with non-Black populations.
Sophia Woodson   +12 more
doaj   +2 more sources

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA [PDF]

open access: yesNeurology and Therapy
Introduction Multiple sclerosis (MS) is a heterogeneous disease affecting a diverse population. Compared with white people with MS (PwMS), Black PwMS have more severe disease and higher incidence of MS, whereas Hispanic PwMS experience earlier onset ...
Sophia Woodson   +12 more
doaj   +2 more sources

Fumarate-based drugs protect against neuroinflammation via upregulation of anti-ferroptotic pathways [PDF]

open access: yesJournal of Neuroinflammation
Ferroptosis is defined as iron dependent non-apoptotic cell death. It is based on peroxidation of polyunsaturated phospholipids and subsequent membrane rupture.
Katinka Fischer   +10 more
doaj   +2 more sources

Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responses [PDF]

open access: yesFrontiers in Immunology
BackgroundThere is a greater risk of complications from severe COVID-19 in immunocompromised patients with multiple sclerosis (pwMS) treated with certain disease-modifying therapies (DMTs), as well as a diminished vaccine response.MethodsIn this ...
Ryan Curtin   +33 more
doaj   +2 more sources

Clinical characteristics and treatment outcomes in multiple sclerosis patients treated with anti-CD20s who switched to fumarates: a retrospective analysis of a US healthcare claims database [PDF]

open access: yesJournal of Comparative Effectiveness Research
Aim: Anti-CD20 monoclonal antibodies and fumarates are common multiple sclerosis (MS) diseasemodifying therapies (DMTs). Data on switching from anti-CD20s to other DMTs are limited.
Aliza B Ben-Zacharia   +8 more
doaj   +2 more sources

Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate) [PDF]

open access: yesDrugs in Context, 2023
Central sleep apnoea (CSA) is a sleep disorder characterized by the repeated cessation or reduction of both airflow and ventilatory effort when sleeping.
Abdulmajeed M Albadi   +2 more
doaj   +2 more sources

Polymorphism and Multi-Component Crystal Formation of GABA and Gabapentin [PDF]

open access: yesPharmaceutics, 2023
This study exploits the polymorphism and multi-component crystal formation of γ-amino butanoic acid (GABA) and its pharmaceutically active derivative, gabapentin.
Daniel Komisarek   +5 more
doaj   +2 more sources

Pharmacomicrobiomics in Psoriasis: Microbiome–Drug Interactions Across Systemic Treatments [PDF]

open access: yesLife
Psoriasis is a chronic immune-mediated skin disease with highly variable responses to systemic therapies. Emerging evidence highlights the microbiome as a potential modulator of drug efficacy and toxicity. Gut bacteria can enzymatically metabolize drugs,
Umberto Santaniello   +6 more
doaj   +2 more sources

How should we do in the selection and follow-up of systemic conventional treatments in psoriasis? [PDF]

open access: yesExploration of Musculoskeletal Diseases, 2023
There is an increasing need for appropriate effective treatment and long-term disease control in patients with psoriasis because of the decreased quality of life, increased physicosocial deficits and associated co-morbidities.
Sevgi Akarsu
doaj   +1 more source

Home - About - Disclaimer - Privacy